Epileptic seizures in patients with Alzheimer’s disease

Neurodegenerative diseases are one of the leading causes of epileptic seizures with onset in later life. Particular attention is paid to Alzheimer's disease (AD), as a disease that accounts for up to 70% of cases of all types of dementia, and, according to the literature, shares genetic and pathophysiological mechanisms with epilepsy. This paper reviews the literature on the prevalence of epilepsy in AD patients. The reasons for the widely varying data (ranging from 0.5 to 64%) depending on the selected population, the reliability of the established diagnosis, the form and genetic characteristics of the disease, as well as the examination methods used, are considered. The main risk factors for the development of AD and epilepsy, semiotics and features of seizures in patients with AD, as well as approaches to the treatment of such patients, are also covered.

Authors

Institutions

Publication Details

Journal
S S Korsakov Journal of Neurology and Psychiatry
Published
2025-12-09
DOI
https://doi.org/10.17116/jnevro202512511136
Primary Topic
Alzheimer's disease research and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Epileptic seizures in patients with Alzheimer’s disease

N. V. Kukina, С. Г. Бурд, А. В. Лебедева, I I Kovaleva et al.
S S Korsakov Journal of Neurology and Psychiatry
Alzheimer's disease research and treatments
article

Epileptic seizures in patients with Alzheimer’s disease

N. V. Kukina, С. Г. Бурд, А. В. Лебедева, I I Kovaleva, А Н Боголепова, N A Osinovskaya, Yu. V. Rubleva, E V Makhnovich, A P Efimenko, Е. А. Коваленко, T.A. Bokitko, G.A. Alekseeva, E. A. Gileva
article en

Abstract

Neurodegenerative diseases are one of the leading causes of epileptic seizures with onset in later life. Particular attention is paid to Alzheimer's disease (AD), as a disease that accounts for up to 70% of cases of all types of dementia, and, according to the literature, shares genetic and pathophysiological mechanisms with epilepsy. This paper reviews the literature on the prevalence of epilepsy in AD patients. The reasons for the widely varying data (ranging from 0.5 to 64%) depending on the selected population, the reliability of the established diagnosis, the form and genetic characteristics of the disease, as well as the examination methods used, are considered. The main risk factors for the development of AD and epilepsy, semiotics and features of seizures in patients with AD, as well as approaches to the treatment of such patients, are also covered.

S S Korsakov Journal of Neurology and PsychiatryVol. 125(11)
Pirogov Russian National Research Medical University (RU), Federal Center of Brain Research and Neurotechnologies, Federal Medical-Biological Agency (RU)
Openalex Percentile: Top 52%
Alzheimer's disease research and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Epileptic seizures in patients with Alzheimer’s disease — N. V. Kukina, С. Г. Бурд, et al. · S S Korsakov Journal of Neurology and Psychiatry (2025) | TGRS Research Map | TGRS